Neos con­sid­er­ing of­fers af­ter re­ject­ing PDL’s $300M bid: Reuters

Neos Ther­a­peu­tics $NEOS may be ask­ing for a bid­ding war af­ter re­ject­ing a takeover of­fer from PDL Bio­Phar­ma that came in last week. A source fa­mil­iar with the mat­ter told Reuters Tues­day Neos will con­sid­er of­fers from oth­er po­ten­tial buy­ers.

It’s the fourth time Neos has jilt­ed PDL. Neos, a mak­er of at­ten­tion deficit dis­or­der treat­ments based out of Texas, re­ceived iden­ti­cal of­fers from PDL in June, Ju­ly and Sep­tem­ber of this year. Each one of­fered to buy Neos for $300 mil­lion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER